| 摘要 |
The invention relates to a medicament for topical application for the purpose of stopping bleedings and/or closing wounds and/or promoting wound healing, which as active substances - produced conventionally of allogenic plasma or tissue or recombinantly -contains fibrinogen or fibrin, thrombin and one or several transglutaminase(s), wherein the medicament, as a further active substance, contains one or several protease inhibitor(s) selected from the group consisting of serpins that do not have inhibiting effects on collagenases and elastases, all of the active substances being of allogenic origin and having been subjected to a process for virus depletion and/or virus inactivation, with the proviso that the virus inactivation of the one or several protease inhibitor(s) has not been carried out in the presence of the other active substances.
|
